Spread the love

Hospital chain on Wednesday reported Rs 172 crore profit after tax (PAT) for the fourth quarter ended March 31 — a 58% year-on-year (YoY) jump on a low base of the corresponding period of the previous year.

The company had a PAT of Rs 109 crore in Q4FY21. The revenues rose 12% YoY to Rs 1,298 crore.

However on a quarter-on-quarter (QoQ) basis – the profit after tax declined 32% and revenues fell by 7%.

The earnings before interest, tax, depreciation and ammortisation (EBITDA) margin stood at 24.8% for the quarter, compared to 24.1% in the corresponding period in FY21 and 27.6% in Q3 FY22.

Bed occupancy in Q4FY22 stood at 68%. About 7% of total occupied beds used for Covid-19 patients compared to 1% in Q3FY22.

Average revenue per occupied bed (ARPOB) rose Rs 63,500 versus Rs 56,100 in Q4FY21.

Max Healthcare stated that the performance in Q4 was impacted by the Omicron wave with low hospitalisations. However, the Omicron wave impacted the non-Covid admissions substantially.

The company expects the second half of the quarter to witness a strong recovery, which was partly fuelled by the international medical tourism bouncing back to 90% of the pre-covid levels in March 22.

“As part of our inorganic growth strategy, we have announced four transactions, including purchase of two prime land parcels in Gurugram,” said Abhay Soi, chairman and MD, Max Healthcare.

“These will have a combined potential to add 2,200 beds in the coming years

in addition to the ongoing brownfield expansions. As we step into the new fiscal year, we are confident of continuing our robust performance,” Soi added.


Leave a Reply

Your email address will not be published. Required fields are marked *